Lv2
120 积分 2024-06-14 加入
1626-P: Liver-Specific Silencing of INHBE with ARO-INHBE, an siRNA Therapeutic, for Metabolic Diseases
2个月前
已关闭
Mechanistic Pharmacokinetics and Pharmacodynamics of GalNAc-siRNA: Translational Model Involving Competitive Receptor-Mediated Disposition and RISC-Dependent Gene Silencing Applied to Givosiran
2个月前
已完结
Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview
3个月前
已完结
Therapeutic siRNA Loaded to RISC as Single and Double Strands Requires an Appropriate Quantitative Assay for RISC PK Assessment
5个月前
已完结
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics
5个月前
已完结
Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2
皖公网安备34019202002308
